9/8/2008

The FDA released a list of 20 medicines being investigated for potential adverse effects to provide early warnings to consumers and health care professionals. The list includes Eli Lilly and Co.'s Cymbalta, an antidepressant, and Purdue Pharma's OxyContin, a pain medication. Companies expressed support for the agency's drug-safety efforts, but some are concerned that data presented to patients lack context and may affect the course of their treatment.

Related Summaries